Journal article
Clinical utility of FDG PET
The journal of medical investigation, Vol.51(1-2), pp.14-19
02/2004
DOI: 10.2152/jmi.51.14
PMID: 15000251
Abstract
The aim of this article is to introduce the clinical utility of FDG PET as oncologic imaging. PET (positron emission tomography) is a newly developed imaging tool, and it has increased the accuracy of metabolic mapping of numerous malignancies, with significant impact on the management of cancer patients for initial staging, restaging and therapy monitoring. PET can provide functional information in addition to morphology from conventional imaging modalities. 18F-labeled 2-fluoro-2-deoxyglucose (FDG) is the most commonly used PET tracer and FDG PET can demonstrate the activity of glucose metabolism throughout the entire body in a single session. We describe the clinical utility of FDG in PET and display images of normal distribution and of patients with head and neck and lung cancer.
Details
- Title: Subtitle
- Clinical utility of FDG PET
- Creators
- Hideki Otsuka - Division of Nuclear Medicine, Department of Radiology, University of Iowa, USAMichael GrahamAkiko KuboHiromu Nishitani
- Resource Type
- Journal article
- Publication Details
- The journal of medical investigation, Vol.51(1-2), pp.14-19
- Publisher
- Japan
- DOI
- 10.2152/jmi.51.14
- PMID
- 15000251
- ISSN
- 1343-1420
- eISSN
- 1349-6867
- Language
- English
- Date published
- 02/2004
- Academic Unit
- Radiology; Radiation Oncology
- Record Identifier
- 9984047979802771
Metrics
18 Record Views